Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
Open Access
- 21 August 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Type 2 diabetes mellitus (T2DM) is associated with a high rate of comorbidity, including osteoporosis and peptic ulcers. Proton pump inhibitors (PPIs) are a group of acid-suppressing drugs commonly used for treating peptic ulcers. However, observational studies have reported an association between PPI therapy and osteoporotic fractures. This study investigated the association between PPI use and hip fracture (HFx) among patients with T2DM. We conducted this population-based propensity-matched retrospective cohort study using the National Health Insurance Research Database in Taiwan. Patients newly diagnosed with T2DM between 2000 and 2008 were identified. After excluding those who previously used PPIs or suffered HFx, 398,885 patients were recruited (44,341 PPI users; 354,544 non-users). HFx risk data from 2000 to 2013 were collected to calculate the cumulative rate of HFx in these two groups. Sensitivity analyses were conducted to evaluate the effects of PPI dose. After propensity score matching of 1:4, 44,431 and 177,364 patients were assigned to the PPI user and non-user groups, respectively. PPI user group showed an increased risk of HFx with an adjusted hazard ratio of 1.41 (95% CI 1.29–1.54) without dose–response relationship. Thus, there is an increased risk of HFx in patients with T2DM receiving long-term PPI treatment.Keywords
Funding Information
- Kaohsiung Medical University (KMU-TC108A02-0)
- Kaohsiung Municipal Ta-Tung Hospital (kmtth-106-040)
This publication has 41 references indexed in Scilit:
- Proton pump inhibitor use and risk of hip fractures among community‐dwelling persons with Alzheimer's disease—a nested case‐control studyAlimentary Pharmacology & Therapeutics, 2018
- Osteoporosis, Fractures, and DiabetesInternational Journal of Endocrinology, 2014
- Use of proton pump inhibitors is associated with lower trabecular bone density in older individualsBone, 2013
- Dose‐dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activityThe FEBS Journal, 2013
- The Risk of Hip Fractures in Older Individuals With DiabetesDiabetes Care, 2007
- Association Between Bone Mass and Fractures in Children: A Prospective Cohort StudyJournal of Bone and Mineral Research, 2006
- Factors Associated With Falls in Older Patients With Diffuse PolyneuropathyJournal of the American Geriatrics Society, 2002
- Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P OverloadNephron, 2002
- Influence of nonenzymatic glycation on biomechanical properties of cortical boneBone, 2001
- Effect of hyperparathyroidism on the control of diabetes mellitus.1986